Literature DB >> 10692238

Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice.

M Jacobs1, N Brown, N Allie, B Ryffel.   

Abstract

Neutralization of TNF or disruption of TNF-R1 leads to fatal Mycobacterium bovis BCG infection. Here we used TNF-LT-alpha-deficient mice to test whether a complete disruption of TNF and LT-alpha reduces further host resistance to BCG infection. The bacterial burden especially in the lungs of TNF-LT-alpha-deficient mice was significantly increased and the mice succumbed to infection between 8 and 10 weeks. In the absence of TNF-LT-alpha the granulomatous response was severely impaired and delayed. The cells in the granulomas of TNF-LT-alpha-deficient mice expressed low levels of MHC class II and ICAM-1. They contained a few T cells and F4/80-positive macrophages expressing little iNOS and acid phosphatase activity. By contrast, the lethal action of endotoxin was dramatically reduced in BCG-infected TNF-LT-alpha-deficient mice. In summary, in the absence of TNF-LT-alpha the recruitment and activation of mononuclear cells in response to BCG infection were significantly delayed and reduced resulting in immature granulomas allowing uncontrolled fatal infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692238     DOI: 10.1006/clim.2000.4835

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  21 in total

Review 1.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Identification of a major locus, TNF1, that controls BCG-triggered tumor necrosis factor production by leukocytes in an area hyperendemic for tuberculosis.

Authors:  Aurelie Cobat; Eileen G Hoal; Caroline J Gallant; Leah Simkin; Gillian F Black; Kim Stanley; Jean-Philippe Jaïs; Ting-Heng Yu; Anne Boland-Auge; Ghislain Grange; Christophe Delacourt; Paul van Helden; Jean-Laurent Casanova; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Clin Infect Dis       Date:  2013-06-25       Impact factor: 9.079

3.  Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.

Authors:  D R Roach; H Briscoe; B M Saunders; W J Britton
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

5.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

Authors:  Cecile M Fremond; Vladimir Yeremeev; Delphine M Nicolle; Muazzam Jacobs; Valerie F Quesniaux; Bernhard Ryffel
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

6.  Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.

Authors:  S Magez; B Stijlemans; G Caljon; H-P Eugster; P De Baetselier
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice.

Authors:  Delphine Nicolle; Cécile Fremond; Xavier Pichon; André Bouchot; Isabelle Maillet; Bernhard Ryffel; Valerie J F Quesniaux
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

8.  Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor.

Authors:  Sergio M Pontejo; Carolina Sanchez; Begoña Ruiz-Argüello; Antonio Alcami
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

Review 9.  Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF.

Authors:  S Ehlers
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

10.  Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.

Authors:  Michael B Drennan; Delphine Nicolle; Valerie J F Quesniaux; Muazzam Jacobs; Nasiema Allie; Joseph Mpagi; Cécile Frémond; Hermann Wagner; Carsten Kirschning; Bernhard Ryffel
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.